Nutriband, Inc.
(NASDAQ : NTRB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.80%538.921.0%$620.17m
DHRDanaher Corp. -0.05%253.400.7%$585.73m
MDTMedtronic Plc 0.11%89.850.6%$583.63m
ABTAbbott Laboratories -0.07%108.570.8%$575.86m
ISRGIntuitive Surgical, Inc. 0.49%201.690.8%$423.09m
BSXBoston Scientific Corp. 0.28%37.381.0%$330.24m
ALGNAlign Technology, Inc. 2.32%242.156.4%$284.23m
BDXBecton, Dickinson & Co. 0.85%248.621.0%$275.13m
SYKStryker Corp. 0.05%199.031.3%$261.82m
EWEdwards Lifesciences Corp. 0.65%95.710.4%$254.94m
IDXXIDEXX Laboratories, Inc. 0.41%352.163.8%$222.44m
BAXBaxter International, Inc. 0.25%64.391.8%$197.51m
AAgilent Technologies, Inc. -0.66%117.991.7%$197.14m
DXCMDexCom, Inc. 2.24%76.201.9%$179.19m
SWAVShockwave Medical, Inc. 2.75%196.420.0%$170.71m

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.